AstraZeneca enters late-stage COVID-19 vaccine trial
Tuesday, September 1, 2020 - 00:30
in Health & Medicine
Multinational pharmaceutical company AstraZeneca announced it has started Phase III clinical trials in the United States of its COVID-19 candidate vaccine.